UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPI
5176
Farmland Partners
FPI
$432M
| $1.17M | ﹤0.01% |
99,254
+24,144
| +32% | +$283K |
|
5177
PUT
Extra Space Storage
EXR
$31.6B
| $1.17M | ﹤0.01% |
+7,800
| New | +$1.28M |
|
5178
Sinclair Inc
SBGI
$1.03B
| $1.16M | ﹤0.01% |
72,160
+23,217
| +47% | +$391K |
|
5179
CALL
JetBlue
JBLU
$2.29B
| $1.16M | ﹤0.01% |
148,100
+51,400
| +53% | +$348K |
|
5180
Mayville Engineering Co
MEC
$617M
| $1.16M | ﹤0.01% |
73,803
-82,462
| -53% | -$1.51M |
|
5181
State Street SPDR Portfolio Europe ETF
SPEU
$745M
| $1.16M | ﹤0.01% |
29,107
-715
| -2% | -$29.8K |
|
5182
Kiniksa Pharmaceuticals
KNSA
$5.93B
| $1.16M | ﹤0.01% |
58,598
+9,091
| +18% | +$207K |
|
5183
CALL
Celsius Holdings
CELH
$7.03B
| $1.16M | ﹤0.01% |
+44,000
| New | +$1.31M |
|
|
PSTX
5184
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $1.16M | ﹤0.01% |
120,549
+50,832
| +73% | +$265K |
|
5185
Replimune Group
REPL
$1.01B
| $1.16M | ﹤0.01% |
95,447
+4,430
| +5% | +$53.8K |
|
|
PTLE
5186
PTL Ltd
PTLE
$62.2M
| $1.16M | ﹤0.01% |
+1,384
| New | +$657K |
|
|
CTLP
5187
DELISTED
Cantaloupe
CTLP
| $1.15M | ﹤0.01% |
120,724
+67,933
| +129% | +$618K |
|
|
WDI
5188
Western Asset Diversified Income Fund
WDI
$681M
| $1.15M | ﹤0.01% |
80,551
+15,161
| +23% | +$228K |
|
5189
Getty Images
GETY
$183M
| $1.15M | ﹤0.01% |
531,174
+483,776
| +1,021% | +$1.58M |
|
5190
FerroAtlántica
GSM
$839M
| $1.14M | ﹤0.01% |
299,829
+261,359
| +679% | +$1.12M |
|
5191
Gladstone Investment Corp
GAIN
$661M
| $1.14M | ﹤0.01% |
85,775
+54,718
| +176% | +$747K |
|
5192
Cerence
CRNC
$414M
| $1.14M | ﹤0.01% |
144,614
+21,653
| +18% | +$109K |
|
5193
CALL
Becton Dickinson
BDX
$48.2B
| $1.13M | ﹤0.01% |
5,000
| – | – |
|
|
IFLN
5194
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
$307M
| $1.13M | ﹤0.01% |
62,728
-256
| -0.4% | -$4.69K |
|
|
OSG
5195
Octave Specialty Group
OSG
$222M
| $1.13M | ﹤0.01% |
89,528
+70,333
| +366% | +$848K |
|
5196
Anika Therapeutics
ANIK
$287M
| $1.13M | ﹤0.01% |
68,724
+61,184
| +811% | +$1.21M |
|
5197
Voyager Therapeutics
VYGR
$201M
| $1.13M | ﹤0.01% |
199,310
+175,047
| +721% | +$1.13M |
|
5198
Unisys
UIS
$217M
| $1.13M | ﹤0.01% |
178,470
+144,500
| +425% | +$1.01M |
|
5199
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.68B
| $1.13M | ﹤0.01% |
18,815
+3,309
| +21% | +$195K |
|
5200
OppFi
OPFI
$803M
| $1.13M | ﹤0.01% |
147,003
+125,668
| +589% | +$793K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.